98 related articles for article (PubMed ID: 11424410)
1. [Combination therapy of eucovorin and 5-FU for advanced gastric cancer].
Sasaki T; Maeda Y; Hayashi C
Nihon Rinsho; 2001 Apr; 59 Suppl 4():381-5. PubMed ID: 11424410
[No Abstract] [Full Text] [Related]
2. [Leucovorin and 5-FU for advanced gastrointestinal cancer].
Sasaki T; Maeda Y; Kobayashi T
Gan To Kagaku Ryoho; 1999 Mar; 26(4):440-6. PubMed ID: 10097740
[TBL] [Abstract][Full Text] [Related]
3. [Standard chemotherapy for gastric cancer].
Sasaki T; Kobayashi T; Okamoto R; Omuro Y
Nihon Rinsho; 2001 Apr; 59 Suppl 4():350-7. PubMed ID: 11424405
[No Abstract] [Full Text] [Related]
4. Chemotherapy of metastatic gastric cancer.
Wils J
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():395-8. PubMed ID: 10895185
[No Abstract] [Full Text] [Related]
5. [Clinical evaluation of leucovorin and 5-fluorouracil].
Sasaki T
Gan To Kagaku Ryoho; 1995 Jul; 22(8):1001-8. PubMed ID: 7611750
[TBL] [Abstract][Full Text] [Related]
6. [Biweekly regimen of high dose of leucovorin, 5-fluorouracil, and paclitaxel for patients with advanced gastric cancer].
Feng JF; Lu JW; Sun XF
Ai Zheng; 2004 Dec; 23(12):1704-6. PubMed ID: 15601565
[TBL] [Abstract][Full Text] [Related]
7. [Leucovorin.5-FU therapy for advanced gastric cancer as a neoadjuvant chemotherapy].
Kitamura M; Arai K; Iwasaki Y; Sasaki T; Maeda Y; Kobayashi T
Gan To Kagaku Ryoho; 1995 Dec; 22(14):2115-7. PubMed ID: 8607625
[No Abstract] [Full Text] [Related]
8. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
[TBL] [Abstract][Full Text] [Related]
9. [Patient with stomach cancer with metastases. What is the value of chemotherapy?].
Wilke H; Stahl M; Vanhoefer U
MMW Fortschr Med; 2003 Nov; 145(48):39-42. PubMed ID: 14724998
[TBL] [Abstract][Full Text] [Related]
10. [Correlative analysis between serum dihydropyrimidine dehydrogenase, activity, concentration of 5-fluorouracil and adverse events in the treatment of advanced gastric cancer patients].
Peng RJ; Dong QM; Shi YX; Cao Y; Zhou ZM; Yuan ZY; Li S; Li H; Jiang WQ
Ai Zheng; 2006 Aug; 25(8):1039-43. PubMed ID: 16965690
[TBL] [Abstract][Full Text] [Related]
11. [Combination chemotherapy for gastric cancer including LV/5-FU].
Sasaki T; Maeda Y; Kandaba-shi K; Ono M
Gan To Kagaku Ryoho; 2004 Nov; 31(12):1952-6. PubMed ID: 15570919
[TBL] [Abstract][Full Text] [Related]
12. [Combination of levofolinate calcium and 5-fluorouracil].
Sasaki T
Gan To Kagaku Ryoho; 2000 Feb; 27(2):315-22. PubMed ID: 10700909
[TBL] [Abstract][Full Text] [Related]
13. Modulation of FU with high-dose folinic acid is effective for treatment of patients with gastric carcinoma.
Machover D; Ulusakarya A; Goldschmidt E
J Clin Oncol; 2008 Jan; 26(1):164. PubMed ID: 18165654
[No Abstract] [Full Text] [Related]
14. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis.
Seo HY; Kim DS; Choi YS; Sung HJ; Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
Cancer Chemother Pharmacol; 2009 Feb; 63(3):433-9. PubMed ID: 18398608
[TBL] [Abstract][Full Text] [Related]
16. A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma.
Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
Hepatogastroenterology; 2003; 50(54):2259-63. PubMed ID: 14696512
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel and leucovorin-modulated infusional 5-fluorouracil combination chemotherapy for metastatic gastric cancer.
Cho BC; Kim JH; Kim CB; Sohn JH; Choi HJ; Lee YC; Ahn JB
Oncol Rep; 2006 Mar; 15(3):621-7. PubMed ID: 16465422
[TBL] [Abstract][Full Text] [Related]
18. [Methotrexate and 5-fluorouracil with leucovorin therapy in advanced gastric cancer: the enhancement of 5-fluorouracil antitumor activity by leucovorin].
Sugiura I; Ogasawara T; Kinoshita T; Ono Y; Onizuka T; Nagata K; Kamiya O; Ohara K; Hoshino A
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1938-40. PubMed ID: 3496053
[No Abstract] [Full Text] [Related]
19. A phase i study of bolus 5-fluorouracil and leucovorin combined with weekly paclitaxel (FLTAX) as first-line therapy for advanced gastric cancer.
Matsubara J; Shimada Y; Takashima A; Takahari D; Hirashima Y; Okita NT; Nakajima TE; Kato K; Hamaguchi T; Yamada Y; Shirao K
Jpn J Clin Oncol; 2008 Aug; 38(8):540-6. PubMed ID: 18628316
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy options for gastric cancer.
Meyerhardt JA; Fuchs CS
Semin Radiat Oncol; 2002 Apr; 12(2):176-86. PubMed ID: 11979419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
